Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Hyakuna N, Shimomura Y, Watanabe A, Taga T, Kikuta A, Matsushita T, Kogawa K, Kawakami C, Horikoshi Y, Iwai T, Okamoto Y, Tsurusawa M, Asami K; Japanese Childhood Cancer and Leukemia Study Group (JCCLSG). Hyakuna N, et al. J Pediatr Hematol Oncol. 2014 Jan;36(1):22-9. doi: 10.1097/MPH.0000000000000039. J Pediatr Hematol Oncol. 2014. PMID: 24136019 Free PMC article.
[Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
Hirota T, Fujimoto T, Katano N, Tsurasawa M, Eguchi H, Nakadate N, Kamitamari A, Kawakami K, Nishikawa K, Asami K, Shirahata A, Koizumi S, Mugishima H, Gushiken T, Hyakuna N, Imaizumi M, Komatu K, Takitani K, Miyake M, Yanase T. Hirota T, et al. Among authors: hyakuna n. Rinsho Ketsueki. 1997 Nov;38(11):1177-82. Rinsho Ketsueki. 1997. PMID: 9423334 Clinical Trial. Japanese.
Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan.
Iwai T, Yokota S, Nakao M, Okamoto T, Taniwaki M, Onodera N, Watanabe A, Kikuta A, Tanaka A, Asami K, Sekine I, Mugishima H, Nishimura Y, Koizumi S, Horikoshi Y, Mimaya J, Ohta S, Nishikawa K, Iwai A, Shimokawa T, Nakayama M, Kawakami K, Gushiken T, Hyakuna N, Fujimoto T, et al. Iwai T, et al. Among authors: hyakuna n. Leukemia. 1999 Jan;13(1):38-43. doi: 10.1038/sj.leu.2401241. Leukemia. 1999. PMID: 10049058
Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia.
Nakamura A, Tsurusawa M, Kato A, Taga T, Hatae Y, Miyake M, Mimaya J, Onodera N, Watanabe A, Watanabe T, Kanegane H, Matsushita T, Iwai A, Hyakuna N, Gushi K, Kawakami T, Sekine I, Izichi O, Asami K, Kikuta A, Tanaka A, Fujimoto T; Children's Cancer and Leukemia Study Group. Nakamura A, et al. Among authors: hyakuna n. Leuk Lymphoma. 2001 Jul;42(3):393-8. doi: 10.3109/10428190109064596. Leuk Lymphoma. 2001. PMID: 11699404
Minimal residual disease in early phase of chemotherapy reflects poor outcome in children with acute lymphoblastic leukemia--a retrospective study by the Children's Cancer and Leukemia Study Group in Japan.
Okamoto T, Yokota S, Katano N, Seriu T, Nakao M, Taniwaki M, Watanabe A, Asami K, Kikuta A, Koizumi S, Kawakami T, Ohta S, Miyake M, Watanabe T, Iwai A, Kamitamari A, Ijichi O, Hyakuna N, Mimaya J, Fujimoto T, Tsurusawa M. Okamoto T, et al. Among authors: hyakuna n. Leuk Lymphoma. 2002 May;43(5):1001-6. doi: 10.1080/10428190290021641. Leuk Lymphoma. 2002. PMID: 12148878
Favourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: a report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group.
Tsurusawa M, Taga T, Horikoshi Y, Ogawa A, Kikuta A, Kanegane H, Matsushita T, Hyakuna N, Shimomura Y, Ohshima K; Lymphoma Committee of Japanese Childhood Cancer and Leukemia. Tsurusawa M, et al. Among authors: hyakuna n. Leuk Lymphoma. 2008 Apr;49(4):734-9. doi: 10.1080/10428190701851356. Leuk Lymphoma. 2008. PMID: 18398741 Clinical Trial.
Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Yamaji K, Okamoto T, Yokota S, Watanabe A, Horikoshi Y, Asami K, Kikuta A, Hyakuna N, Saikawa Y, Ueyama J, Watanabe T, Okada M, Taga T, Kanegane H, Kogawa K, Chin M, Iwai A, Matsushita T, Shimomura Y, Hori T, Tsurusawa M; Japanese Childhood Cancer Leukemia Study Group. Yamaji K, et al. Among authors: hyakuna n. Pediatr Blood Cancer. 2010 Dec 15;55(7):1287-95. doi: 10.1002/pbc.22620. Pediatr Blood Cancer. 2010. PMID: 20535816 Clinical Trial.
Assessment of late cardiotoxicity of pirarubicin (THP) in children with acute lymphoblastic leukemia.
Shimomura Y, Baba R, Watanabe A, Horikoshi Y, Asami K, Hyakuna N, Iwai A, Matsushita T, Yamaji K, Hori T, Tsurusawa M; Japanese Childhood Cancer and Leukemia Study Group (JCCLSG). Shimomura Y, et al. Among authors: hyakuna n. Pediatr Blood Cancer. 2011 Sep;57(3):461-6. doi: 10.1002/pbc.23012. Epub 2011 Feb 4. Pediatr Blood Cancer. 2011. PMID: 21298773 Clinical Trial.
50 results